Logo image of ULBI

ULTRALIFE CORP (ULBI) Stock Fundamental Analysis

NASDAQ:ULBI - Nasdaq - US9038991025 - Common Stock - Currency: USD

6.67  +0.01 (+0.15%)

After market: 6.32 -0.35 (-5.25%)

Fundamental Rating

5

Overall ULBI gets a fundamental rating of 5 out of 10. We evaluated ULBI against 95 industry peers in the Electrical Equipment industry. ULBI has only an average score on both its financial health and profitability. ULBI is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make ULBI a good candidate for value investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ULBI had positive earnings in the past year.
ULBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ULBI reported negative net income in multiple years.
Of the past 5 years ULBI 4 years had a positive operating cash flow.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

With a decent Return On Assets value of 2.36%, ULBI is doing good in the industry, outperforming 75.79% of the companies in the same industry.
ULBI has a better Return On Equity (3.88%) than 75.79% of its industry peers.
ULBI has a Return On Invested Capital of 4.34%. This is in the better half of the industry: ULBI outperforms 70.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ULBI is significantly below the industry average of 10.11%.
The 3 year average ROIC (3.14%) for ULBI is below the current ROIC(4.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.36%
ROE 3.88%
ROIC 4.34%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 3.05%, ULBI is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
ULBI's Profit Margin has declined in the last couple of years.
The Operating Margin of ULBI (6.19%) is better than 76.84% of its industry peers.
In the last couple of years the Operating Margin of ULBI has remained more or less at the same level.
Looking at the Gross Margin, with a value of 25.16%, ULBI is in line with its industry, outperforming 56.84% of the companies in the same industry.
In the last couple of years the Gross Margin of ULBI has declined.
Industry RankSector Rank
OM 6.19%
PM (TTM) 3.05%
GM 25.16%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ULBI is destroying value.
ULBI has more shares outstanding than it did 1 year ago.
ULBI has more shares outstanding than it did 5 years ago.
ULBI has a worse debt/assets ratio than last year.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

ULBI has an Altman-Z score of 1.87. This is not the best score and indicates that ULBI is in the grey zone with still only limited risk for bankruptcy at the moment.
ULBI has a Altman-Z score (1.87) which is comparable to the rest of the industry.
ULBI has a debt to FCF ratio of 3.04. This is a good value and a sign of high solvency as ULBI would need 3.04 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.04, ULBI is doing good in the industry, outperforming 76.84% of the companies in the same industry.
A Debt/Equity ratio of 0.37 indicates that ULBI is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.37, ULBI perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 3.04
Altman-Z 1.87
ROIC/WACC0.57
WACC7.61%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

ULBI has a Current Ratio of 3.22. This indicates that ULBI is financially healthy and has no problem in meeting its short term obligations.
ULBI has a better Current ratio (3.22) than 77.89% of its industry peers.
ULBI has a Quick Ratio of 1.70. This is a normal value and indicates that ULBI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.70, ULBI is in the better half of the industry, outperforming 64.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.7
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ULBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.28%.
ULBI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.31% yearly.
ULBI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.74%.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)-51.28%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)2.74%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.03%

3.2 Future

The Earnings Per Share is expected to grow by 43.60% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.34% on average over the next years. This is quite good.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.55, the valuation of ULBI can be described as rather expensive.
ULBI's Price/Earnings ratio is a bit cheaper when compared to the industry. ULBI is cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.25. ULBI is valued slightly cheaper when compared to this.
ULBI is valuated cheaply with a Price/Forward Earnings ratio of 7.03.
Based on the Price/Forward Earnings ratio, ULBI is valued cheaply inside the industry as 96.84% of the companies are valued more expensively.
ULBI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 17.55
Fwd PE 7.03
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 88.42% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ULBI is valued cheaply inside the industry as 95.79% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.29
EV/EBITDA 10.21
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULBI's earnings are expected to grow with 43.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)5.31
EPS Next 2Y43.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ULBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ULTRALIFE CORP

NASDAQ:ULBI (5/30/2025, 8:00:01 PM)

After market: 6.32 -0.35 (-5.25%)

6.67

+0.01 (+0.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)07-23 2025-07-23
Inst Owners75.44%
Inst Owner Change-4.88%
Ins Owners3.08%
Ins Owner Change1.28%
Market Cap110.92M
Analysts82.86
Price Target14.28 (114.09%)
Short Float %1.77%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.25%
Min EPS beat(2)-93.46%
Max EPS beat(2)-15.03%
EPS beat(4)1
Avg EPS beat(4)-36.27%
Min EPS beat(4)-93.46%
Max EPS beat(4)54.06%
EPS beat(8)4
Avg EPS beat(8)83.21%
EPS beat(12)6
Avg EPS beat(12)64.09%
EPS beat(16)7
Avg EPS beat(16)37.99%
Revenue beat(2)2
Avg Revenue beat(2)5.56%
Min Revenue beat(2)3.65%
Max Revenue beat(2)7.48%
Revenue beat(4)3
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)7.48%
Revenue beat(8)6
Avg Revenue beat(8)5.23%
Revenue beat(12)8
Avg Revenue beat(12)4.34%
Revenue beat(16)10
Avg Revenue beat(16)3.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)-17.39%
EPS NY rev (3m)-17.39%
Revenue NQ rev (1m)-6.42%
Revenue NQ rev (3m)-6.42%
Revenue NY rev (1m)-3.11%
Revenue NY rev (3m)-3.11%
Valuation
Industry RankSector Rank
PE 17.55
Fwd PE 7.03
P/S 0.64
P/FCF 6.29
P/OCF 5.52
P/B 0.81
P/tB 1.65
EV/EBITDA 10.21
EPS(TTM)0.38
EY5.7%
EPS(NY)0.95
Fwd EY14.22%
FCF(TTM)1.06
FCFY15.89%
OCF(TTM)1.21
OCFY18.11%
SpS10.42
BVpS8.2
TBVpS4.03
PEG (NY)0.26
PEG (5Y)5.31
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 3.88%
ROCE 5.58%
ROIC 4.34%
ROICexc 4.55%
ROICexgc 7.31%
OM 6.19%
PM (TTM) 3.05%
GM 25.16%
FCFM 10.17%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 3.04
Debt/EBITDA 3.31
Cap/Depr 54.03%
Cap/Sales 1.42%
Interest Coverage 250
Cash Conversion 131.58%
Profit Quality 333.52%
Current Ratio 3.22
Quick Ratio 1.7
Altman-Z 1.87
F-Score3
WACC7.61%
ROIC/WACC0.57
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.28%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-38.1%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.74%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.03%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.72%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1545.08%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y3304.24%
OCF growth 3Y56.62%
OCF growth 5YN/A